Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics-Reference-Cited by-同舟云学术

Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics

Published:2016-03 Issue: Volume:350-352 Page:25-30
ISSN:0300-483X
Container-title:Toxicology
language:en
Short-container-title:Toxicology

Author:

Worek Franz,Koller Marianne,Thiermann Horst,Wille Timo

Funder

German Ministry of Defence

Publisher

Elsevier BV

Subject

Toxicology

Reference28 articles.

1. Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivators;Ashani;Biochem. Pharmacol.,2003

2. Toxicokinetics of nerve agents;Benschop,2001

3. The acute treatment of nerve agent exposure;Cannard;J. Neurol. Sci.,2006

4. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime: against tabun and soman poisoning of mice;Clement;Arch. Toxicol.,1987

5. The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine;Clement;Biopharm. Drug Dispos.,1995

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AChE reactivation in precision-cut lung slices following organophosphorus compound poisoning;Toxicology Letters;2024-02

2. Butyrylcholinesterase nanodepots with enhanced prophylactic and therapeutic performance for acute organophosphorus poisoning management;Journal of Materials Chemistry B;2021

3. No promising antidote 25 years after the Tokyo subway sarin attack: A review;Legal Medicine;2020-11

4. Organophosphorus compounds and oximes: a critical review;Archives of Toxicology;2020-06-06

5. A novel high‐performance liquid chromatography with diode array detector method for the simultaneous quantification of the enzyme‐reactivating oximes obidoxime, pralidoxime, and HI‐6 in human plasma;Drug Testing and Analysis;2020-04-23